Drug Shortage Report for BENDAMUSTINE HYDROCHLORIDE FOR INJECTION

Last updated on 2022-07-20 History
Report ID 164970
Drug Identification Number 02509172
Brand name BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Common or Proper name Bendamustine Hydrochloride for Injection House Std.
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) BENDAMUSTINE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 vial x 100 mg
ATC code L01AA
ATC description ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-07-19
Estimated end date 2022-12-30
Actual end date
Shortage status Actual shortage
Updated date 2022-07-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-07-20 English Compare
v2 2022-07-19 French Compare
v1 2022-07-19 English Compare

Showing 1 to 3 of 3